MDR1 C3435T Polymorphisms Correlate With Cyclosporine Levels in De Novo Renal Recipients

This publication has 23 references indexed in Scilit:

• The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients
  Pharmacogenetics, 2004
• MDR1 Haplotypes Do Not Affect the Steady‐State Pharmacokinetics of Cyclosporine in Renal Transplant Patients
  The Journal of Clinical Pharmacology, 2003
• Amlodipine, but not MDR1 polymorphisms, alters the pharmacokinetics of cyclosporine A in Japanese kidney transplant recipients1
  Transplantation, 2003
• Cyclosporine Microemulsion (Neoral®) Absorption Profiling and Sparse-sample Predictors During the First 3 Months after Renal Transplantation
  American Journal of Transplantation, 2002
• ABSORPTION PROFILING OF CYCLOSPORINE MICROEMULSION (NEORAL) DURING THE FIRST 2 WEEKS AFTER RENAL TRANSPLANTATION1
  Transplantation, 2001
• Identification of functionally variant MDR1 alleles among European Americans and African Americans
  Clinical Pharmacology & Therapeutics, 2001
• Effect of high-dose cyclosporine on etoposide pharmacodynamics in a trial to reverse P-glycoprotein ( MDR1 gene) mediated drug resistance
  Cancer Chemotherapy and Pharmacology, 2000
• NEORAL MONITORING BY SIMPLIFIED SPARSE SAMPLING AREA UNDER THE CONCENTRATION-TIME CURVE
  Transplantation, 1999
• VARIABLE ORAL ABSORPTION OF CYCLOSPORINE
  Transplantation, 1996
• Relevance of p-glycoprotein for the enteral absorption of cyclosporin A: in vitro-in vivo correlation
  British Journal of Pharmacology, 1996